Abstract: Omega-3 polyunsaturated fatty acids
Data from Office of Dietary Supplements, National Institute of Health (NIH) [28] . Tbsp denotes tablespoon.
There are two recognised biosynthesis pathways for n-3 LC-PUFA (Figure 1 ), including the presently accepted pathway [29] and conventional metabolic pathway [30] . In the former pathway, DHA was produced from DPA via sequential desaturation and elongation combined with a final β-oxidation where tetracosapentaenoic acid (24:5n-3) is chain-shortened by two carbons. The latter conventional metabolic pathway, in contrast, consists of direct conversion of DHA from DPA under the catalysis of delta-4 desaturase enzyme. The molecular evidence for delta-4 desaturase that supported the conventional metabolic pathway for n-3 LC-PUFA biosynthesis was first demonstrated by Park et al. [31] . Further research is needed to clarify the specific pathway for n-3 LC-PUFA biosynthesis in the human body, but most studies have confirmed a very low rate of conversion of ALA to n-3 LC-PUFA, in particular, to DHA (0.05% or less) [32] . The specific mechanism(s) by which biosynthesis of these essential FA occurs is limited in man and is still largely unknown. Calder [3] suggested that a possible cause for this limitation is the competition between biosynthetic pathways of ALA conversion to n-3 LC-PUFA and linoleic acid (18:2n-6) conversion to n-6 LC-PUFA as the two pathways employ the same set of enzymes. In addition, based on previous animal studies, deficiencies of insulin [33] , protein [34] and microminerals [35] might lead to lower delta-6 desaturase enzyme activity, thus contributing to the low efficiency of this pathway. pathways employ the same set of enzymes. In addition, based on previous animal studies, deficiencies of insulin [33] , protein [34] and microminerals [35] might lead to lower delta-6 desaturase enzyme activity, thus contributing to the low efficiency of this pathway. [30] and Sprecher [29] ).
Due to the limitation of n-3 LC-PUFA biosynthesis in the human body from ALA, the best way of acquiring these essential FA is from dietary sources [36] . Fish and seafood currently are the major sources of n-3 LC-PUFA with high concentration ranges across seafood species [1, 37] . The average content of total n-3 LC-PUFA in 150 g wet weight of wild caught Australian fish, shellfish, prawns, and lobsters are 350, 250, 180, and 160 mg respectively, with a range of species also having markedly higher contents than these average values [1] . The level of these FA for the two common fish species farmed in Australia -Atlantic salmon, and barramundi -examined by Nichols et al. [38] are 980 and 790 mg/100 g, respectively. Compared to the previous results [1] , the concentration of n-3 LC-PUFA for these farmed fish had decreased significantly by 50% or more. Changes in feed ingredients for farmed fish, in which fish meal and fish oils have been substituted by non-traditional oil sources such as plant and/or chicken oils were the reasons for this trend [38] . Foods derived from animals have much lower n-3 LC-PUFA content in comparison to marine products (Table 2 ). [30] and Sprecher [29] ).
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n-3 LC-PUFA Consumption and Chronic Diseases
The biological functions of n-3 LC-PUFA are firstly represented by their occurrence in all cellular membranes in all tissues of the body, and in particular, at high content levels in the retina, brain, and myocardium [48, 49] . For example, due to a high concentration of DHA in the membranes of the human retina and brain, it plays an important role in regulating membrane receptors, membrane-bound enzymes and transduction signals [48] . In addition, n-3 LC-PUFA have the potential to transform into a group of mediators such as the E-series and D-series resolvins at the expense of inflammation mediators from arachidonic acid (20:4n-6, ARA) which is the primary cause of various chronic disease treatments [49, 50] . Chronic inflammation that persists for a long time has a strong link with the development of many chronic diseases including cancer, cardiovascular (CVD), neurodegenerative, and respiratory diseases [3, 51] . Moreover, there is a positive correlation between n-3 PUFA dietary consumption and incorporation of these FA into cell membranes [52, 53] that explains a positive effect of adequate dietary n-3 PUFA consumption on inhibiting chronic diseases.
Cardiovascular diseases refer to a collective term for heart and/or blood vessels related diseases that are by far, the most leading cause of mortality worldwide with 17.9 million deaths reported in 2018 [13] . Therefore, the effects of n-3 PUFA on major CVD including coronary heart disease (CHD) and stroke have been reported in numerous studies [54] [55] [56] . One of the potential roles of n-3 PUFA in reducing the risk of CHD is by counteracting many steps of atherosclerosis [57] , the major cause of CHD [58] . Novel findings [59] demonstrated that enriched-DHA canola oil supplementation could reduce the risk of CHD by improving high-density lipoprotein cholesterol, triglycerides, and blood pressure. In addition, previous meta-analyses established the link between increasing intakes of n-3 LC-PUFA and reducing the risk of CHD death by 10-30% [54] . In terms of stroke, dietary consumption of n-3 PUFA can reduce the volume of ischemic stroke [60] by promoting antioxidant enzyme activities or partly acting as an antioxidant. n-3 PUFA can provide further benefits relating to stroke post-treatments [55] , by generating other important responses such as neuranagenesis and revascularization. The latest meta-analysis of prospective cohort studies [61] supported a strong inverse relationship between daily fish intake and the risk of stroke. Following CVD, cancer is the second most common cause of death [13] . Clinical and epidemiological studies have demonstrated the role of n-3 LC-PUFA in either reducing the risk of developing cancer or improving chemotherapy outcomes in existing cancer patients of several common types of cancer [3, 62] . Long-term studies by Kato et al. [63] , Terry et al. [64] and Takezaki et al. [65] concluded that increased consumption of dietary n-3 LC-PUFA lowered the risk of colorectal, prostate and lung cancer, respectively. Van Blarigan et al. [66] also reported that higher intake of n-3 LC-PUFA improved disease-free survival by 28% in colon cancer patients. The effect of these PUFA is more varied. While Holmes et al. [56] showed no relation between fish consumption and breast cancer, recent studies confirmed the positive impact of n-3 fat on not only inhibiting [67, 68] , but also reducing fatigue [69] , in breast cancer patients. In contrast to the large number of studies that confirmed the positive effects of n-3 PUFA on these two major chronic diseases, other research findings reported neutral, inconclusive or even possible negative effects [62] . For instance, there was no statistically significant association between major CVD events and n-3 PUFA supplementation based on a meta-analysis of previous randomized clinical trials [70] . Similarly, results from a large prospective cohort study by Rhee et al. [71] reported a neutral effect of n-3 PUFA intake on the risk of major CVD in healthy women aged ≥45 years. With respect to cancer, Holmes et al. [72] showed that there was no relationship between fish consumption and breast cancer, while in one case, the intake of n-3 PUFA was claimed to induce the risk of basal cell carcinoma on skin cancer [73] .
Apart from CVD and cancer, large studies have recognised the role of n-3 LC-PUFA in regards to brain related cognitive treatments and other common chronic diseases such as rheumatoid arthritis, type-2 diabetes and obesity. Relating to brain issues in humans, bioactivities of n-3 LC-PUFA, particularly DHA, play an important role in neural membrane structure, neurotransmission, and signal transduction [74] , and positive effects on treatment of different neurodegenerative and neurological disorders [75] . Lower n-3 PUFA intakes have been reported to induce the risk of Alzheimer's disease [76] , while increased fish oil intakes for Parkinson's disease patients resulted in a significant reduction in depressive symptoms [77] . Examining rheumatoid arthritis, Abdulrazaq et al. [78] reported that a majority of studies confirmed the beneficial effect of utilising n-3 LC-PUFA at doses of 3-6 g/day on pain relief in patients. Findings on the benefits of n-3 PUFA consumption in type-2 diabetes and obesity remain inconsistent. While some authors have recognised that n-3 PUFA intake can reduce the incidence of diabetes [79, 80] , the findings from a systematic review and meta-analysis reported by Wu et al. [81] suggested a neutral effect of EPA + DHA and seafood consumption on the development of diabetes. Similarly, no significant relationship between n-3 PUFA and obesity was reported in the review by Albracht-Schulte et al. [82] . In contrast, high fish intake in men could lower the risk of being overweight [83] , although an opposite result was observed in women with higher fish consumption [84] .
The controversies regarding the role of n-3 PUFA in chronic diseases may be explained by many factors such as dose, duration, baseline intake [85] , specific type of the chronic disease and risk group [86] . Due to this continuous debate and variations in experimental design, it has not been very evident from current scientific literature and medical opinion confirming or rejecting the beneficial effects of n-3 PUFA in reducing the risk of human chronic diseases [62] . Therefore, large and unified clinical trials need to be conducted to conclusively identify the exact role of n-3 PUFA as independent or supplementary factors in specific chronic diseases.
Lipid Metabolism in Ruminants: Obstacles to Enriching Milk Fat with n-3 PUFA
Since all of the long-chain FA in milk fat are derived from the absorption of fatty acids from the small intestine and body fat reserves that have both originated from dietary FA [17, 87] , manipulating the diet or feeding regime is the most popular way to alter milk fat composition. However, the efficiency of this approach in ruminants is still limited due to rumen microbial fermentation [88] .
Dietary lipid sources for ruminants are mainly from forages, supplements or concentrates including cereal grains, oilseeds and animal fats. Lipids derived from forages contain largely glycolipids and phospholipids, while triglycerides are found primarily in supplements [89] . Once dietary lipids enter the rumen, lipolysis occurs and it involves hydrolysis of ester linkages to release free fatty acids for the next biohydrogenation (BH) process [88] (Figure 2 ). 
Recent Attempts to Increase n-3 PUFA Content In Dairy-Derived Products
Up to the present time, the nutritional manipulation of feeding regimes and supplementation with lipid sources containing high amounts of n-3 PUFA [17, 96] are the major approaches to improving n-3 PUFA content in dairy products. In contrast, current efforts to employ genetic programmes in this theme have not yet yielded significant enhancement because the FA profile of milk processed products primarily depends on the FA composition of raw milk [97] [98] [99] . Therefore, current studies mostly focus on milk content as the principal route of increasing n-3 PUFA in other processed products.
Feeding Regime
Previous studies had demonstrated that feeding regime, particularly changes in forage sources and feeding systems, had significant effects on shorter chain n-3 PUFA, but minor effects on n-3 LC-PUFA concentrations in both dairy ewes and cows (Table 3) . This is because lipids from pasture sources contain abundant amounts of ALA [100, 101] , but not EPA, DHA and DPA. For example, ALA content of fresh ryegrass varieties, a popular pasture used for ruminants worldwide, ranges from 62 to 74% of total fatty acids [102] . However, the pasture conservation processes, particularly grass wilting in the field, generally cause the oxidative loss of forage PUFA, subsequently and markedly reducing the content of ALA in hay or silage [100] . Wilting ryegrass 24 h in glasshouse, for instance, reduced the percentage of ALA by 33% compared to unwilted grass [103] . Therefore, dairy ruminants that are kept in grazing systems or have free access to fresh grass produced much higher proportions of ALA in milk compared with animals fed conserved grass (hay and silage) [104] [105] [106] [107] . These results appear to be supported by the higher ALA intake of animals fed or grazed on fresh pastures. Under the activity of rumen microbes, unsaturated fatty acids (UFA) including PUFA are hydrogenated to monounsaturated FA (MUFA) and ultimately, saturated FA (SFA) through the addition of a double bond of two hydrogen atoms. The principal role of this process is to maintain a stable rumen environment by reducing the toxic effects of free UFA on bacterial growth in the rumen [89] . Due to the high rate of hydrolysis and BH, only small amounts of PUFA from the diet can pass through the rumen into the duodenum for absorption [90] . According to Shingfield et al. [91] , dietary ALA in the rumen can be hydrogenated into 18:0 (Figure 4 ) at the rate of 85% to 100%. Both in vivo [92] and in vitro [93] studies have confirmed an extensive BH of dietary EPA and DHA that was greater than 90%. In contrast to ALA, these PUFA are not completely hydrogenated into SFA, but numerous intermediates are produced including a majority of UFA and much lesser amounts of SFA [94] . The most recent in vitro study [95] suggests that while the reduction of the double bond at the closest position to the carboxyl group is the main BH pathway of EPA and DPA (Figure 3 ), this process is much less important for DHA. In addition, these authors stated that the possible interspecies differences between bovine and ovine BH of n-3 LC-PUFA is directly correlated with slower and less complete BH observed in cattle, especially for EPA and DPA. However, the specific pathways for BH of individual n-3 LC-PUFA still remain unclear.
Apart from ruminal BH, given the relatively low absorption rate from the small intestine into the mammary gland at 49% for ALA, and ranging from 14% to 33% for EPA, and from 13% to 25% for DHA [17] , it is not surprising that the proportion of these PUFA in dairy products is generally very low. Principal strategies for increasing n-3 PUFA in milk and milk products, therefore, have been to minimize the biohydrogenation effects of ruminal microbes and/or improving the absorption rate of these FA into the mammary gland. ovine milk products (Table 4) 
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Lipid supplementation has been used as an effective tool to improve animal performance due to its significant energy contribution [101] , and it can also alter milk fat composition because of the high content of essential FA [114, 115] . Fish oils and marine products, oilseeds and vegetable oils are the main sources that have been employed in ruminant diets to enhance the concentrations of health beneficial n-3 PUFA and n-3 LC-PUFA in milk and milk products [101] .
Oil Seed and Vegetable Oil
Plant-derived fat is the most common fat source in ruminant supplements, and includes both oilseeds and extracted vegetable oils. This is because these materials not only contain a high concentration of PUFA [116] , protein and energy [117] , but are also more readily available and cheaper than other (marine) sources [22] . Therefore, a number of studies have examined the effects of oilseed and vegetable oils on the concentration of health beneficial n-3 PUFA in both bovine and ovine milk products (Table 4 ). Based on previously reported results, the addition of flaxseed or linseed supplements in ruminant diets is a more effective strategy to enrich milk n-3 PUFA compared to other plant fat supplementation methods (Table 4 ). Due to its very high content in ALA at approximately 53% of all FA [118] , cows or sheep supplemented with flaxseed had substantial enhancement of this shorter chain n-3 PUFA in milk products (Table 4) . Oil infusion is also considered an effective form of providing plant oil supplements that increases the escape rate of UFA from the BH of rumen microbes, thus enhancing the availability of n-3 PUFA for absorption [17] . Khas et al. [124] reported that adding 160 g/day of infused free ALA in the diet for lactating cows increased ALA content in milk by 41-fold, and also resulted in significant increases in milk EPA and DPA by two-fold and three-fold, respectively. However, supplementation with vegetable seed and oils only marginally increased milk EPA, DHA, and DPA in both bovines and ovines, with the percentages of these FA often lower than 0.1 g/100g FA (Table 4 ). These findings indicated that the endogenous biosynthesis pathway of these n-3 LC-PUFA from dietary ALA in dairy animals is limited.
Marine Lipid Sources
Feeding dairy animals with marine oil resulted in the highest n-3 LC-PUFA concentration in milk and milk products (Table 5 ) among all types of lipid supplements examined. Previous studies also confirmed the efficiency of utilising rumen-protected forms of marine products that were markedly higher than in the untreated controls; mainly as a result of the lesser extent of ruminal biohydrogenation with the rumen-protected diets [125] . Kitessa et al. reported that the content of EPA and DHA, which are generally scanty in milk (Tables 3 and 4) , could be increased by supplementing both dairy cattle [126] and ewes [127] with rumen-protected fish oil. The proportion of DHA, the most essential n-3 LC-PUFA, observed in these studies, exceeded 1% of the total FA. Similarly, an effective incorporation rate of DHA from a marine algae supplement, an alternative to fish oil into milk, was also confirmed by a number of studies (Table 5 ). This transfer rate appears to be higher as observed in ovine [128] than in bovine [129] . Results presented in Table 5 also indicate that supplementing fish oil is more advantageous than marine algae in terms of improving milk EPA and DPA content.
Recent focus on achieving quantitatively significant amounts of n-3 PUFA per standard serve of milk and milk products has occurred [45, 46] . This absolute FA concentration data may be more accurate than the proportion (expressed as %FA) itself, since the fat percentage of milk from different species varies widely [130] , and such quantitative data can potentially assist consumers in purchasing decisions. One serve of fresh milk produced from grazing ewes supplemented with rumen-protected EPA + DHA contains 62 mg of total n-3 LC-PUFA, three-fold higher than the control group [45] . This result is higher than the concentration of total EPA + DHA + DPA in one serve of cooked lamb meat (55 mg) reported by Flakemore et al. [131] . In achieving 60 mg/serving, this sheep milk can also be considered as achieving a "good source" level of n-3 LC-PUFA, adhering to Food Standards Australia and New Zealand (FSANZ) [132] . Although the inclusion of fish oil into ruminant diets might have a negative effect on meat quality such as possible rancidity and abnormal flavour in cooked or grilled lamb [133] , no side effects on milk and milk products have been reported. Nguyen et al. [46] observed no differences in sensory eating traits between ripened cheese processed from milk produced by dairy sheep supplemented with rumen-protected marine source and the unsupplemented group. However, the higher cost of the marine oil source possibly limits its utilization as a routine supplementation for dairy ruminants [101] . Table 4 . Effect of supplementing ruminants with plant-derived dietary sources on n-3 PUFA concentration in milk and milk products (g/100 g fatty acids). 
Genetic Manipulation as a Potential Tool for the Enrichment of Dairy Products with n-3 PUFA
Attempts at understanding and estimating genetic parameters influencing milk FA content that may be beneficial for human health had been made a decade ago [146, 147] . Up to the present (Table 6) were consistently reported in dairy cows [147] [148] [149] and dairy sheep [150] , indicating a low impact of genetics or breed on the concentration of n-3 PUFA. This observation probably arises because the fatty acids longer than 18 carbon chains are not de novo synthesized in the mammary gland, but are circulated from the blood which contains lipids that originated from the diet [94] . Moderate heritabilities for the whole group of n-3 PUFA were reported by Boichard et al. [151] and Maroteau et al. [152] , and could be explained by major contribution of the shorter chain n-3 PUFA. First identified in the human genome in 2000 [153] , fatty acid desaturase 1 and 2 (FADS1 and FADS2) are considered as the major candidate genes that regulate the endogenous synthesis of n-3 LC-PUFA from ALA in mammals including ruminants [154] [155] [156] [157] [158] . The first effort to define the association between these two encoding genes and n-3 PUFA in the milk of Holstein cows [159] found that three significant single nucleotide polymorphism (SNP) markers within FADS1 and FADS2 were associated with EPA. Apart from the two well-characterized FADS1 and FADS2 genes, Ibeagha-Awemu et al. [160] uncovered more potential candidate genes with several novel SNPs that were significantly associated with milk EPA and DPA. Consequently, by employing these potential genetic markers, future research can investigate the specific relationships between combining genetics and other environmental strategies such as nutritional supplementation for elevating n-3 LC PUFA in milk. 
Conclusions
Since first being reported some four decades ago, the number of studies confirming the beneficial effects of n-3 PUFA on reducing the risk of chronic diseases including cardiovascular disease, cancer, mental illnesses, age-related cognitive decline, and inflammatory diseases were over and above those that found neutral or adverse effects. Specific mechanisms with respect to the independent and/or supplementary influences of n-3 PUFA on human health, however, remain controversial and need further investigations. Consumption of seafood as the major source of n-3 LC-PUFA is still generally insufficient, resulting in the need for enhancing the concentration of these beneficial n-3 LC-PUFA in other common dietary sources for human consumption. Attempts to increase the content of n-3 LC-PUFA in milk and milk products, which are important components of the human diet, has therefore been a major research focus for the last two decades. Current studies generally demonstrate that the processes of lipolysis combined with dietary lipid BH in the rumen are the main obstacles in modulating n-3 LC-PUFA content of dairy products. In addition, the biosynthetic pathway of these FA from the precursor ALA, is limited, with only minor conversion occurring. Thus, supplementing ruminants with marine-derived sources in a rumen-protected form is at this time, one of the best strategies to increase n-3 LC-PUFA content in milk and its processed products. Yet, there seems to be a lack of evaluation regarding the economic efficiency of different supplemented ingredients utilized in the current research. We propose that further studies are required to better elucidate the n-3 LC-PUFA biosynthesis pathway from ALA, together with the BH mechanism of individual n-3 LC-PUFA. A more comprehensive knowledge of these aspects would be a guiding principle for further research on increasing the escape rate of dietary PUFA from the rumen and their absorption rate from the small intestine into milk. Genetically modifying oilseeds as an alternative and sustainable source of dietary n-3 LC-PUFA for ruminants should be taken into account when future supplies of fish oil may not be sufficient. Finally, activities of regulated genes on the concentration of n-3 PUFA and their reaction to non-genetic factors such as lipid supplementation for specific dairy species also needs to be better defined. Identified knowledge gaps regarding the activities of candidate genes regulating the concentrations of n-3 PUFA and the responses of ruminants to specific lipid supplementation regimes are also critical to a greater understanding of nutrition-genetics interactions driving lipid metabolism.
